InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Lefenfeld Michael, Director. Officer active across 1 company, notably Immunome Inc.. In total, 3 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €17k. History available since 24 May 2021. The latest transaction was filed on 15 January 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations3 total
13,875 shares@ US$4.0074.5% of flowCommon StockSEC:0001104659-23-004005:0
600 shares@ US$17.800.0004% mcap50.0% of flowCommon StockSEC:0001104659-21-072621:0
Ideal exit: 18 Feb 2022 (T+270)
600 shares@ US$17.8050.0% of flowCommon StockSEC:0001104659-21-072621
Ideal exit: 18 Feb 2022 (T+270)
3 of 3 declarations
About Lefenfeld Michael
Michael Lefenfeld is a Board Member at Immunome Inc. He contributes to the governance of the company, bringing his expertise in the biotechnology field. His role is essential in guiding Immunome in its research and development projects, as well as in its business strategy.
